Suppr超能文献

错配修复缺陷型直肠癌免疫治疗后发生直肠狭窄。病例报告及文献综述。

Rectal stenosis after immunotherapy in a mismatch repair deficient rectal cancer. Case report and review of literature.

作者信息

Büttner Marcel, Schempf Ulrike, Bachmann Robert, Hoffmann Rüdiger, Schroeder Christopher, Mattern Sven, Singer Stephan, Steinle Marc, Niyazi Maximilian, Bitzer Michael, Gani Cihan

机构信息

Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.

Department of Internal Medicine I, University Hospital Tuebingen 72076 Tuebingen, Germany.

出版信息

Clin Transl Radiat Oncol. 2025 Apr 9;53:100953. doi: 10.1016/j.ctro.2025.100953. eCollection 2025 Jul.

Abstract

We report the case of a 57-year-old male patient who presented with a circumferential cT3 cN1 rectal adenocarcinoma in the mid rectum. The tumor was found to be mismatch repair deficient/microsatellite instable (dMMR/MSI). Instead of multimodality treatment with chemoradiotherapy immunotherapy with Dostarlimab was initiated. Treatment was well-tolerated in general and endoscopy and MRI showed early signs of treatment response. Despite this, the patient developed intestinal obstruction due to scarring that required repeat balloon dilations. In contrast to other oncological treatments, obstructions may worsen during immunotherapy in dMMR rectal cancers. This information has to be considered when patients are consulted regarding the optimal treatment after disease.

摘要

我们报告了一例57岁男性患者,其直肠中段出现环周性cT3 cN1直肠腺癌。发现该肿瘤为错配修复缺陷/微卫星不稳定(dMMR/MSI)。未采用放化疗的多模式治疗,而是开始使用度伐利尤单抗进行免疫治疗。总体而言,治疗耐受性良好,内镜检查和磁共振成像显示出早期治疗反应迹象。尽管如此,患者因瘢痕形成出现肠梗阻,需要反复进行球囊扩张。与其他肿瘤治疗不同,dMMR直肠癌在免疫治疗期间梗阻情况可能会恶化。在就疾病后的最佳治疗咨询患者时,必须考虑这一信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da35/12041760/e6736c51e381/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验